An AI-designed vaccine against all variants of the coronavirus SARS-CoV-2 – designed using an AI-powered platform developed ...

Parabilis Medicines has revealed the financial details behind its recently announced IPO, hoping to raise up to $475 million ...

Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed. Advances in ...

Analysts suggested the deaths could overshadow the PFS results, and the safety trade-off may make it harder for ADC ...

And yet, ask most HCPs whether their experience of engaging with pharma has meaningfully improved, and the answer is usually ...

Final draft guidance from reimbursement authority NICE recommends Elahere (mirvetuximab soravtansine) for treating ...

ASCO's Sunday plenary session will open with results of a 2,109-person global prostate cancer study that showed adding ...

New trial data with Johnson & Johnson's nipocalimab, Biogen and UCB's dapirolizumab pegol, and Merck KGaA's enpatoran have ...

The London company, based at the King's Cross life sciences and tech hub and led by former scientists at AstraZeneca, ...

The Coalition for Epidemic Preparedness Innovations (CEPI) has made $60 million available for clinical trials of vaccines for ...

Servier has signed the largest licensing deal in its history, paying $1.55 billion upfront for Edgewise Therapeutics' ...

Walk through an automotive assembly plant, and you'll see a masterclass in precision. Automated lines, zero-waste workflows, ...